NANOBIOTIX to Participate in Jefferies London Healthcare Conference
NANOBIOTIX (NASDAQ: NBTX) said company management will participate in a fireside chat at the Jefferies London Healthcare Conference on Monday, November 17, 2025. The session is scheduled for 3:00 PM GMT / 10:00 AM ET / 4:00 PM CET in London.
Presenters listed are Laurent Levy, Chief Executive Officer, and Bart van Rhijn, Chief Financial & Business Officer. The fireside chat will be webcast live from the company’s investors events page, with a replay available after the event.
NANOBIOTIX (NASDAQ: NBTX) ha indicato che la direzione dell'azienda parteciperà a una fireside chat alla Jefferies London Healthcare Conference a Londra lunedì 17 novembre 2025. La sessione è prevista per le 15:00 GMT / 10:00 ET / 16:00 CET a Londra.
I relatori elencati sono Laurent Levy, Amministratore Delegato, e Bart van Rhijn, Direttore Finanziario & Responsabile delle Attività. La fireside chat sarà trasmessa in diretta tramite webcast dalla pagina degli eventi per investitori dell'azienda, con una replica disponibile dopo l'evento.
NANOBIOTIX (NASDAQ: NBTX) afirmó que la dirección de la empresa participará en una charla junto al fuego en la Jefferies London Healthcare Conference en Londres el lunes 17 de noviembre de 2025. La sesión está programada para las 3:00 PM GMT / 10:00 AM ET / 4:00 PM CET en Londres.
Los presentadores listados son , y Bart van Rhijn, Director Financiero y de Negocios. La charla junto al fuego se transmitirá en directo desde la página de eventos para inversores de la empresa, con una reproducción disponible después del evento.
NANOBIOTIX (NASDAQ: NBTX)는 회사 경영진이 2025년 11월 17일 월요일 런던에서 열리는 Jefferies London Healthcare Conference의 파이어사이드 채팅에 참가할 것이라고 밝혔다. 세션은 런던에서 GMT 3:00 PM / ET 10:00 AM / CET 4:00 PM에 예정되어 있습니다.
제 발표자는 Laurent Levy, 최고경영책임자와 Bart van Rhijn, 최고재무책임자 겸 비즈니스 책임자입니다. 파이어사이드 채팅은 회사의 투자자 이벤트 페이지에서 실시간 생중계로 진행되며, 이벤트 후 재방송이 제공됩니다.
NANOBIOTIX (NASDAQ: NBTX) a déclaré que la direction de l'entreprise participera à une conversation au coin du feu lors de la Jefferies London Healthcare Conference à Londres le lundi 17 novembre 2025. La session est prévue pour 15h00 GMT / 10h00 ET / 16h00 CET à Londres.
Les présentateurs listés sont Laurent Levy, Directeur Général, et Bart van Rhijn, Directeur Financier et Responsable des Affaires. La conversation au coin du feu sera diffusée en direct via webcast depuis la page des investisseurs de l'entreprise, avec une rediffusion disponible après l'événement.
NANOBIOTIX (NASDAQ: NBTX) teilte mit, dass das Management des Unternehmens an einem Fireside-Chat bei der Jefferies London Healthcare Conference in London am Montag, dem 17. November 2025 teilnehmen wird. Die Sitzung ist in London für 3:00 PM GMT / 10:00 AM ET / 4:00 PM CET vorgesehen.
Vorgestellte Sprecher sind Laurent Levy, Chief Executive Officer und Bart van Rhijn, Chief Financial & Business Officer. Der Fireside Chat wird live gestreamt von der Investorenevents-Seite des Unternehmens, mit einer Wiederholung nach der Veranstaltung.
NANOBIOTIX (NASDAQ: NBTX) أعلنت أن إدارة الشركة ستشارك في محادثة Fireside خلال مؤتمر Jefferies London Healthcare في لندن يوم الاثنين 17 نوفمبر 2025. من المقرر عقد الجلسة في 3:00 مساءً بتوقيت GMT / 10:00 صباحاً بتوقيت ET / 4:00 مساءً بتوقيت CET في لندن.
المقدمون المذكورون هم لوران ليفي، الرئيس التنفيذي، وبارت فان راينهين، المدير المالي ومسؤول الأعمال. ستُبث محادثة Fireside مباشرة من صفحة فعاليات المستثمرين بالشركة، مع توفر إعادة مشاهدة بعد الحدث.
- None.
- None.
PARIS and CAMBRIDGE, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in a fireside chat at the following conference:
Jefferies London Healthcare Conference
Date: Monday, November 17, 2025
Time: 3pm GMT / 10am ET / 4pm CET
Location: London, UK
Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial & Business Officer of Nanobiotix
Webcast link: Click here
The fireside chat will be webcast live from the events page of the Investors section of the Company’s website. Replay of the webcast will be available following the event.
About NANOBIOTIX
Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The Company’s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.
Incorporated in 2003, Nanobiotix is headquartered in Paris, France and is listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has subsidiaries in Cambridge, Massachusetts (United States) amongst other locations.
Nanobiotix is the owner of more than 25 patent families associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system.
For more information about Nanobiotix, visit us at www.nanobiotix.com or follow us on LinkedIn and Twitter.
Contacts
| Nanobiotix | |
| Communications Department Brandon Owens VP, Communications +1 (617) 852-4835 contact@nanobiotix.com | Investor Relations Department Joanne Choi VP, Investor Relations (US) +1 (713) 609-3150 Ricky Bhajun Director, Investor Relations (EU) +33 (0) 79 97 29 99 investors@nanobiotix.com |
| Media Relations | |
France – HARDY Caroline Hardy +33 06 70 33 49 50 carolinehardy@outlook.fr | Global – uncapped Becky Lauer +1 (646) 286-0057 uncappednanobiotix@uncappedcommunications.com |
Attachment
- 2025-11-10 -- NBTX -- Presenting @ Jefferies -- FINAL
FAQ
When will NANOBIOTIX (NBTX) present at the Jefferies London Healthcare Conference?
Who will represent NANOBIOTIX (NBTX) at the Jefferies London Healthcare Conference?
How can investors watch the NANOBIOTIX (NBTX) fireside chat on November 17, 2025?
What topics will NANOBIOTIX (NBTX) likely cover in the Jefferies London Healthcare Conference fireside chat?
Where is the Jefferies London Healthcare Conference session with NANOBIOTIX (NBTX) being held?
Will there be a replay of the NANOBIOTIX (NBTX) Jefferies conference webcast?
